Core Viewpoint - Oncology Consultants has joined the American Oncology Network (AON), enhancing its ability to provide patient-focused cancer care and access to advanced therapies while maintaining its commitment to high-quality, compassionate care since its establishment in 1982 [1][2][3]. Company Overview - Oncology Consultants is the largest independent community oncology practice in Houston, offering a comprehensive range of services including infusion therapy, radiotherapy, diagnostic imaging, pharmacy services, clinical trials, and genetic testing [9]. - The practice operates 18 locations across South Texas and is staffed by 16 Board-certified medical oncologists, 3 Board-certified radiation oncologists, and 23 advanced practitioners [3][9]. Partnership Benefits - The partnership with AON allows Oncology Consultants to expand its patient services, enhance access to clinical trials, and pursue new growth opportunities while preserving its independence and culture [2][8]. - This collaboration provides the necessary scale, infrastructure, and clinical resources to support innovation in cancer care, while allowing physicians to focus on delivering personalized care [8][10]. AON Overview - American Oncology Network is an alliance of over 350 providers across 21 states, founded in 2018, aimed at ensuring the long-term success of community oncology through innovative healthcare solutions and a physician-led model [10]. - AON is committed to promoting health equity and addressing disparities in cancer care, ensuring all patients have access to necessary care for optimal health outcomes [10].

Core Insights - Small-cap stocks are gaining significant attention, with some stocks in the iShares Russell 2000 ETF experiencing massive gains this year, outperforming larger-cap stocks like Nvidia and Palantir [1][2]. Small-Cap Performance - The iShares Russell 2000 ETF has increased by 11.2% this year, although it still lags behind the S&P 500 [2]. - On September 18, the Russell 2000 index reached an all-time high for the first time since March 15, 2021, ending a streak of 967 trading days without a new high, which is the second longest in the index's history [3]. Notable Small-Cap Stocks - The Oncology Institute (TOI) has seen a remarkable rise of 1,064% this year, increasing from 31 cents to $3.60 per share [3]. - Better Home & Finance (BETR) and ThredUp (TDUP) also performed well, with gains of 602.6% and 578.1% respectively [7]. - ThredUp is valued at over $1.1 billion and is expected to lose 24 cents per share this year, yet its stock price has risen to $9.44 [5]. Market Dynamics - Many small-cap stocks started the year with low share prices, leading to substantial percentage increases with even small dollar gains [3]. - The average stock in the Russell 2000 index now trades for $37 per share, indicating a shift in market dynamics as small stocks rally [6].